We are happy to share a new scientific publication that highlights the potential of using the Phelix phage test in addressing the challenges for diagnosis of borrelia-related infections. Given that tick-borne diseases pose a growing global concern, accurate diagnosis is crucial. Traditional diagnostic tests can be problematic due to the complex immune evasion strategies of Borrelia species. The use of bacteriophages as diagnostic tools is able to overcome these challenges, due to their high specificity and potential for greater sensitivity. The Phelix phage test specifically targets borrelia-specific bacteriophages in biological samples (blood, urine, ticks, etc), which could significantly enhance patient outcomes and public health. Read article HERE
Overcoming the Challenges of Lyme Disease Diagnosis: The Role of Phage-based Testing
- R.E.D. Laboratories
Most recent posts
TRENDING DEZE MAAND
We are excited to introduce MitoSwab™, a groundbreaking and non-invasive test designed to assess mi…
ontdek meer
Exciting News: R.E.D. Laboratories (RED Labs) Partners with IGeneX to Bring Advanced Diagnostic Tes…
ontdek meer
During Lyme Disease Awareness Month, we at R.E.D. Laboratories are committed to sharing new scienti…
ontdek meer